AdventHealth, Anthem Sign Multi-Year Deal to Expand GA Access
AdventHealth and Anthem Blue Cross Blue Shield of Georgia (Anthem) are pleased to announce a new multi-year contractual agreement that ensures continued access to high-quality,...
Category : Healthcare Quality, Patient Safety & Policy
Alzheon to Share ALZ-801 Data at Alzheimer’s Conference July 30′
Valiltramiprosate Evaluated in APOLLOE4 Trial, First Interventional Phase 3 Alzheimer’s Trial Focused on High-Risk APOE4/4 Homozygotes Anti-Amyloid Oligomer Action Underpins Valiltramiprosate’s Potential Benefit in Alzheimer’s...
CARsgen Successfully Defends Its GPC3 CAR-T Patent at the EPO
CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces a favorable outcome in opposition proceedings before the...
Bio-Techne’s Simple Western Used in FDA Approval of ZEVASKYN™ Therapy
Bio-Techne Corporation (NASDAQ: TECH) today announced that its Simple Western™ Technology played a key role in supporting the FDA approval of ZEVASKYN™ (prademagene zamikeracel), the first...
Genomenon & UCB Partner to Boost TK2 Deficiency Awareness and Diagnosis
Genomenon’s Curation and Distribution of Variant Data to Global Clinical Communities Reduces Barriers to Genetic Diagnosis Genomenon, a leader in genomic intelligence, today announced a...
International SOS Calls for Innovation in Crisis Management
New Comprehensive Global Crisis Management White Paper Leads the Way to Transform Crises into Catalysts for Resilience and Innovation International SOS, the leading global security and...
Manitoba Bioscience Group Applauds Government Support for Research
Bioscience Association Manitoba (BAM) welcomes the Manitoba government’s latest announcement to launch a Clinical Trials Office, and the implementation of the Research Manitoba led project,...
Dizal’s ZEGFROVY® Gets FDA Accelerated Approval for NSCLC Treatment
Dizal (SSE:688192), a biopharmaceutical company committed to developing novel medicines for the treatment of cancer and immunological diseases, announced today that the U.S. Food and...
Soligenix: Synthetic Hypericin Successfully Made at Sterling Pharma
Active Ingredient Manufacturing Transfer to the U.S. Complete Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products...
Revolution, Summit to Test RAS(ON) Drugs with Ivonescimab
Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers and Summit Therapeutics Inc. (Nasdaq: SMMT), a...
Nitinotes Gets FDA IDE Approval to Start U.S. Trial of EndoZip™ System
Advancing Minimally Invasive Obesity Treatment with Automated Suturing Technology Nitinotes, developer of the EndoZip™ System, a fully automated suturing platform for endoscopic sleeve gastroplasty (ESG),...
Salesforce Collaborates With UChicago Medicine to Enhance Patient Support
The academic health system will soon handle personalized requests — like prescription refills and appointment scheduling — autonomously with Agentforce for Health to boost efficiency...
Study Validates Geneoscopy’s ColoSense® Real-World Impact
Geneoscopy, Inc., a life sciences company focused on developing diagnostic tests for the advancement of gastrointestinal health, today announced the publication of a new study...
Herspiegel Acquires Decisive to Expand Life Sciences Services
Blending Bold Strategy with Proven Market Access and Health Economics Expertise to Unlock Asset Value Herspiegel, a leader in pharmaceutical commercialization services, today announced the...
Aetna Supports Industry Actions to Simplify Prior Authorization
Company commits to distinctive actions that will make it easier to navigate the health care system, access care, and achieve better health Aetna, a CVS...